12-month price target for Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) now sits at $230

In last trading session, Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) saw 758,787 shares changing hands with its beta currently measuring 1.23. Company’s recent per share price level of $117.12 trading at -$3.26 or -2.71% at ring of the bell on the day assigns it a market valuation of $1.81 Billion. That closing price of MDGL’s stock is at a discount of -17.21% from its 52-week high price of $137.28 and is indicating a premium of 51.49% from its 52-week low price of $56.82. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 146.28 Million shares which gives us an average trading volume of 140.1 Million if we extend that period to 3-months.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

For Madrigal Pharmaceuticals, Inc. (MDGL), analysts’ consensus is at an average recommendation of Overweight while assigning it a mean rating of 2.1. Splitting up the data highlights that, out of 17 analysts covering the stock, 1 rated the stock as a Sell while none recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 13 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$3.86 in the current quarter.

In the face of being in the red today for losing -2.71%, in the last five days MDGL remained trading in the green while hitting it’s week-highest on Monday, Dec 14 when the stock touched $126.82 price level, adding 7.65% to its value on the day. Madrigal Pharmaceuticals, Inc.’s shares saw a change of 28.55% in year-to-date performance and have moved -1.93% in past 5-day. Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) showed a performance of 2.72% in past 30-days. Number of shares sold short was 2.5 Million shares which calculate 0.02 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $171.07 to the stock, which implies a rise of 46.06% to its current value. Analysts have been projecting $123 as a low price target for the stock while placing it at a high target of $230. It follows that stock’s current price would jump +96.38% in reaching the projected high whereas dropping to the targeted low would mean a loss of 5.02% for stock’s current value.

Madrigal Pharmaceuticals, Inc. (MDGL) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 29.2% during past 5 years. In 2020, company’s earnings growth rate is likely to be around -145.9% while estimates for its earnings growth in next 5 years are of 0%

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)’s Major holders

Insiders are in possession of 19.47% of company’s total shares while institution are holding 94.18% percent of that, with stock having share float percentage of 116.95%. Investors also watch the number of corporate investors in a company very closely, which is 188 institutions for Madrigal Pharmaceuticals, Inc. that are currently holding shares of the company. Capital Research Global Investors is the top institutional holder at MDGL for having 1.89 Million shares of worth $223.84 Million. And as of September 29, 2020, it was holding 12.19% of the company’s outstanding shares.

The second largest institutional holder is Baker Brothers Advisors, LLC, which was holding about 1.5 Million shares on September 29, 2020. The number of shares represents firm’s hold over 9.69% of outstanding shares, having a total worth of $178Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

On the other hand, Growth Fund Of America Inc and Smallcap World Fund are the top two Mutual Funds which own company’s shares. As of September 29, 2020, the former fund manager was holding 1001258 shares of worth $118.88 Million or 6.47% of the total outstanding shares. The later fund manager was in possession of 742.92 Thousand shares on September 29, 2020, making its stake of worth around $88.21 Million in the company or a holder of 4.8% of company’s stock.

This Secret NYSE Telecom Trading at $1.36 gets $35.00 Price Target by 2 Analyst!

There is a secret stock that is LOADED with opportunity for savvy investors to make a fortune!

Get all the details here >>


Latest posts